Pfizer reported growth of its quarterly revenue and profit by 45%. Sales of the vaccine against COVID-19 yielded $3.5 billion, which was 59% than forecast. However, after the report was published, the shares grew by 0.3% only.
Why are AstraZeneca stocks growing regardless of bad news? The EU stopped using the vaccine fearing possible thrombosis in patients. The terms of production and supply are violate.